Browsing Tag
Imagion Biosystems
2 posts
Is Imagion Biosystems (ASX: IBX) on the cusp of a breakout? FDA optimism lifts Phase 2 hopes, but market sentiment remains cautious
Imagion Biosystems is progressing toward a key FDA filing and Phase 2 trial for its HER2 imaging agent. Find out why IBX could be at a turning point.
Imagion Biosystems (ASX: IBX) soars 84% after FDA feedback on HER2 breast cancer trial
Imagion Biosystems surged 84% on FDA feedback for its breast cancer imaging trial. Find out what this means for its MagSense tech and investor outlook.